Danone announces further investment in Singapore Digital Lab to accelerate digital health innovation

The investment aims to boost healthy ageing solutions through AI and data-driven tools.

Danone is stepping up its digital innovation efforts with a new investment phase at its Digital Lab (D-Lab) in Singapore, aiming to deepen its commitment to digital health and expanding its global research and innovation (R&I) footprint.

Announced on Wednesday (11 June 2025), the latest funding will boost the lab’s capabilities in digital science, data analytics, and AI-driven health solutions, with a strong focus on nutrition for the ageing population which is an increasingly important health priority across Asia.

This move continues Danone’s ongoing collaboration with the Singapore Economic Development Board (EDB), which dates back to 2018. That year, Danone launched the OneBiome Lab in Singapore to study the gut microbiome, a partnership supported by EDB, Agency of Science, Technology and Research (ASTAR) and other local research bodies.

The digital health services developed as part of these partnerships in Singapore, which enable early screening, continuous monitoring, and nutritional management of health conditions, are now set to be scaled and introduced to global markets.

Christian Stammkoetter, President for Asia, Middle East and Africa, Danone, highlighted Singapore’s strong scientific ecosystem of talent and expertise and strategic partnerships as key to tackling ageing through innovation.

"Through digital technologies, we aim to turn data into actionable insights that improve health outcomes locally and globally," he said.

Chan Ih-Ming, Executive Vice President, Digital Economy and Hub Service Industry Group, EDB, welcomed Danone’s expanded R&D efforts, noting how it complements Singapore’s healthy ageing initiatives and enhance the country’s reputation as a global centre for health innovation.

Danone’s research & innovation network includes major centres such as the Daniel Carasso Center in Paris-Saclay, France, and the Nutricia Research Center in Utrecht, Netherlands. The Singapore D-Lab, which has attracted €30mn in investment over five years, comes as part of the companies aim to solidify its dedication to digital healthcare transformation, developing proprietary technologies to support patients, parents and healthcare professionals.

Among the digital tools developed are the Iron Tracker, a non-invasive screening device for iron-deficiency anaemia; the Stool Tracker, an AI-powered system helping parents monitor their baby’s stool health, and the Growth Tracker, which tracks children’s development. These tools have already been deployed across various markets worldwide.

With this investment, Danone aims to deepen its leadership in health-focused food innovation and deliver on its mission to improve health through food for people everywhere.